Hoshi Iryo-Sanki Co., Ltd. (TYO:7634)
5,100.00
+60.00 (1.19%)
Feb 16, 2026, 1:16 PM JST
Hoshi Iryo-Sanki Revenue
Hoshi Iryo-Sanki had revenue of 3.95B JPY in the quarter ending December 31, 2025, with 7.11% growth. This brings the company's revenue in the last twelve months to 15.45B, up 2.29% year-over-year. In the fiscal year ending March 31, 2025, Hoshi Iryo-Sanki had annual revenue of 15.10B with 2.19% growth.
Revenue (ttm)
15.45B
Revenue Growth
+2.29%
P/S Ratio
1.03
Revenue / Employee
30.90M
Employees
500
Market Cap
15.93B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 15.10B | 324.00M | 2.19% |
| Mar 31, 2024 | 14.78B | 999.00M | 7.25% |
| Mar 31, 2023 | 13.78B | 1.01B | 7.89% |
| Mar 31, 2022 | 12.77B | 962.00M | 8.15% |
| Mar 31, 2021 | 11.81B | 931.00M | 8.56% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Takeda Pharmaceutical Company | 4.46T |
| Otsuka Holdings | 2.47T |
| Chugai Pharmaceutical | 1.26T |
| HOYA Corporation | 915.21B |
| Medical System Network | 129.18B |
| SEED Co.,Ltd. | 33.57B |
| Taiko Pharmaceutical | 6.40B |
| WOLVES HAND | 5.75B |